Effects of cryopreservation on the immunogenicity of porcine arterial allografts in early stages of transplant vasculopathy

Cryobiology. 2005 Oct;51(2):130-41. doi: 10.1016/j.cryobiol.2005.06.006.

Abstract

Background: The number of revascularization procedures including coronary and lower extremity bypass, have increased greatly in the last decade. It suggests a growing need for vascular grafts. Cryopreserved allografts could represent a viable alternative but their immunologic reactivity remains controversial.

Methods: 71 pigs (40 recipients and 31 donors) were used. Two femoral grafts per recipient animal were implanted for 3, 7, and 30 days. Types of grafts: fresh autograft as a control graft (n=19), fresh allograft (n=31) and cryopreserved allograft (n=30). Histological and immunohistochemical studies were performed.

Results: Fresh allografts compared to autografts showed intimal inflammatory infiltration at 3 days (328 vs. 0 macrophages/mm2; P<0.05) and 7 days (962 vs. 139 T lymphocytes/mm2; P<0.05) post-transplantation. At 30 days, there was a loss of endothelial cells, presence of luminal thrombus and aneurismal lesions (total area=15.8 vs. 8.4 mm2; P<0.05). Cryopreservation did not reduce these lesions nor modify endothelial nitric oxide synthase (eNOS) expression nor modify the number of animals that developed anti-SLA antibodies. Moreover, at 7 days, cryopreserved allografts compared to fresh allografts showed a higher expression of P-selectin (5 out of 5 vs. 1 out of 5; P<0.05) and, at 30 days, a greater inflammatory reactivity (2692 vs. 1107 T lymphocytes/mm2 in media; P<0.05) with a trend towards a higher presence of multinucleated giant cells than in the fresh ones.

Conclusions: The cryopreservation method used maintained immunogenicity of allografts and increased the inflammatory reactivity found in fresh allografts up to 30 days of vascular transplantation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aneurysm / pathology
  • Animals
  • Cryopreservation / methods*
  • Cryoprotective Agents / pharmacology
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / pathology
  • Femoral Artery / immunology*
  • Femoral Artery / pathology
  • Femoral Artery / transplantation*
  • Granulocytes / drug effects
  • Granulocytes / immunology
  • Isoantibodies / immunology
  • Macrophages / drug effects
  • Macrophages / immunology
  • Nitric Oxide Synthase Type III / biosynthesis
  • P-Selectin / biosynthesis
  • Swine
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • Thrombosis / pathology
  • Time Factors
  • Transplantation Immunology
  • Transplantation, Autologous / immunology
  • Transplantation, Autologous / methods
  • Transplantation, Homologous / immunology*
  • Transplantation, Homologous / methods

Substances

  • Cryoprotective Agents
  • Isoantibodies
  • P-Selectin
  • Nitric Oxide Synthase Type III